BD to Announce Financial Results for its Second Quarter of Fiscal 2026
Get Alerts BDX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
EPS Growth %: -14.9%
Join SI Premium – FREE
FRANKLIN LAKES, N.J.,
About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media | Investors |
| SVP, Investor Relations |
View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-second-quarter-of-fiscal-2026-302738573.html
SOURCE BD (Becton, Dickinson and Company)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Tamron 17-70mm f/2.8 APS-C Lens for Nikon Z and Canon RF Camera Mounts; Available July 2nd and More Info at B&H
- Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share